Phase II study of pembrolizumab plus olaparib in the treatment of patients with
- This topic has 0 replies, 1 voice, and was last updated 4 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Phase II study of pembrolizumab plus olaparib in the treatment of patients with advanced cholangiocarcinoma.
https://meetinglibrary.asco.org/record/191662/abstract
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.